The commitments at the presidential investment summit, including domestic investment, are well under way, according to Invest SA, an entity managed by the department of trade & industry that is tracking the implementation of the investment commitments. Aspen Pharmacare, SA's largest pharmaceutical group, is investing R3.4bn in a sterile anaesthetics-manufacturing facility. Lorraine Hill, Aspen's group operating officer and responsible pharmacist, said the first phase of the building project had been completed on April 1. The second phase requires internal modifications and will commence in May. Hill said the commercial launch of the facility would be in early 2022 and would require specialised skills, with staff having a detailed understanding of the process and equipment. A new job specification - technical manufacturer, with a minimum entry of a diploma in chemical engineering - will be created. "The role is supported by other specialist roles such as application specialists, elec...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now